Yüklüyor......
Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
INTRODUCTION: Similar outcomes have been observed between patients with rheumatoid arthritis (RA) responding to tocilizumab (TCZ) with methotrexate (MTX) who discontinued vs. continued MTX and between patients receiving MTX who added TCZ vs. switched to TCZ monotherapy. This study examined MTX disco...
Kaydedildi:
| Yayımlandı: | Rheumatol Ther |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer Healthcare
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7211217/ https://ncbi.nlm.nih.gov/pubmed/32232740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-020-00200-z |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|